Archive | September, 2009
1930s Déjà vu
The excerpts below come courtesy of David Rosenberg, chief economist and strategist of Gluskin Sheff & Associates. “An old contact of ours at Merrill Lynch pointed out these articles from the Wall Street Journal after the initial post-crash rally that took the market up some 50% from the interim lows. Sounds eerily similar to what [...]
Continue reading...WealthTrack: A Conversation with Nassim Taleb and Jason Sweig
6 September 2009 – 11:39 pm PST
Comments Off
This week on Consuelo Mack WealthTrack, two unconventional thinkers share their wisdom with us. She talks to Nassim Taleb, “The Black Swan†author and well known Cassandra, about his unconventional, and as it turns out prescient, approach to investing, and Jason Zweig, author of “Your Money and Your Brain†explains the new field of neuroeconomics [...]
Continue reading...Labour Day barbecue …
6 September 2009 – 11:38 pm PST
Comments Off
Source: Dave Granlund, September 4, 2009. Did you enjoy this post? If so, click here to subscribe to updates to Investment Postcards from Cape Town by e-mail.
Continue reading...Good news for South African consumers
6 September 2009 – 10:33 pm PST
Comments Off
There is light at the end of the tunnel for South African consumers. All the local banks are expected to follow Standard Bank’s example shortly and start lowering their lending criteria for households, which could lighten the heavy financial burden of households considerably. Since mid-2005 banks have raised their lending criteria. The National Credit Act [...]
Continue reading...Clolar Gets Cool Reception From FDA and up for Approval (GENZ, VION)
1 September 2009 – 3:22 pm PST
Comments Off
Genzyme Corporation (Nasdaq:GENZ) has a new drug application for their new drug Clofarabine ( Clolar), a leukemia drug that will be used to treat older patients. The Food and Drug Administration criticized the biotech company’s clinical study for Clolar, stating the company failed to perform a randomized controlled study to support their application of the [...]
Continue reading...Investing Legend David Winters Is Betting On Another Crash?
1 September 2009 – 9:22 am PST
Comments Off
Do you know David Winters? Having studied under two legendary value investors Max Heine and Michael Price, Winters has a long history of producing outsized gains: before he was 40, he was overseeing some $35 billion in assets as Chief Investment Officer for Franklin Templeton Advisors. During this period (2001-2004), David outperformed the S&P 500 [...]
Continue reading...Endo Pharmaceuticals Partners Pending FDA decision (ENDP, LON:PSK)
1 September 2009 – 8:00 am PST
Comments Off
Endo Pharmaceuticals (NASDAQ: ENDP) has announced they have partnered up with the U.K. based corporation ProStrakan Group plc (LSE: PSK). The agreement includes the right to commercialize in America, FORTESTA their testosterone gel that is 2 percent. The testosterone transdermal gel is used in testosterone replacement therapy and stays in the categories of the other [...]
Continue reading...Banks and Lenders Lose and Future Looks Bright for Credit Unions
1 September 2009 – 6:00 am PST
Comments Off
The credit crunch isn’t anywhere near over. Mortgage lenders are still facing losses and trying desperately to get rid of REO (Real Estate Owned) properties as a result of foreclosures. Lending institutions are not only reluctant to grant new loans but are closing accounts and decreasing revolving credit lines. The one bright spot seems to [...]
Continue reading...
6 September 2009 – 11:42 pm PST
Comments Off